Spencer Hahn - Research Scientist - PTC Therapeutics, Inc.
Von einem Mystery-Man-Autor
Beschreibung
![Spencer Hahn - Research Scientist - PTC Therapeutics, Inc.](https://onlinelibrary.wiley.com/cms/asset/ff1098c8-b690-460f-a245-e83728df20f2/cen.12515.fp.png)
Guidelines for the management of thyroid cancer - Perros - 2014 - Clinical Endocrinology - Wiley Online Library
![Spencer Hahn - Research Scientist - PTC Therapeutics, Inc.](https://ascpt.onlinelibrary.wiley.com/cms/asset/9ba14377-1596-4d1b-b24a-b24e7dabc60f/cpt2835-gra-0026-m.jpg)
American Society for Clinical Pharmacology and Therapeutics - 2023 - Clinical Pharmacology & Therapeutics - Wiley Online Library
![Spencer Hahn - Research Scientist - PTC Therapeutics, Inc.](https://img.yumpu.com/45297666/1/500x640/gtmb-7-gene-therapy-amp-molecular-biology.jpg)
GTMB 7 - Gene Therapy & Molecular Biology
![Spencer Hahn - Research Scientist - PTC Therapeutics, Inc.](https://pubs.rsc.org/image/article/2021/CB/d1cb00016k/d1cb00016k-f4_hi-res.gif)
Chemogenomics for drug discovery: clinical molecules from open access chemical probes - RSC Chemical Biology (RSC Publishing) DOI:10.1039/D1CB00016K
![Spencer Hahn - Research Scientist - PTC Therapeutics, Inc.](http://www.hanmiscience.co.kr/science/images/mobile/news/news_333_1.jpg)
Hanmi SCIENCE
![Spencer Hahn - Research Scientist - PTC Therapeutics, Inc.](https://static.cambridge.org/binary/version/id/urn:cambridge.org:id:binary:45293:20160716055400893-0661:49339tbl15_1.png?pub-status=live)
Functional networks of events that modulate phenotypic manifestation of cancer (Part 4) - Systems Biology of Cancer
Spencer Hahn - Research Scientist - PTC Therapeutics, Inc.
![Spencer Hahn - Research Scientist - PTC Therapeutics, Inc.](https://iiif.elifesciences.org/lax/03270%2Felife-03270-fig8-v2.tif/full/,1500/0/default.jpg)
Increased H+ efflux is sufficient to induce dysplasia and necessary for viability with oncogene expression
![Spencer Hahn - Research Scientist - PTC Therapeutics, Inc.](https://i1.rgstatic.net/publication/344407086_Vitamin_D_Supplementation_to_Prevent_Redevelopment_of_Basal_Cell_Carcinoma_BCC_A_Phase_III_Randomized_Clinical_Trial_Protocol/links/5f721c3e299bf1b53efc7ec5/largepreview.png)
PDF) Vitamin D Supplementation to Prevent Redevelopment of Basal Cell Carcinoma (BCC): A Phase III Randomized Clinical Trial Protocol
Spencer Hahn - Research Scientist - PTC Therapeutics, Inc.
aus
pro Erwachsener (Preis variiert je nach Gruppengröße)